Simplify Medical completes enrollment for Simplify Disc trial at 16 US sites — 5 insights

Written by Megan Wood | February 14, 2018 | Print  |

Simplify Medical concluded enrollment for its U.S. investigational device exemption trial testing the Simplify cervical artificial disc.

Here are five insights:

 

1. The company capped enrollment at 166 patients at 16 sites across the country.

 

2. The trial is assessing the Simplify Disc for one-level cervical implantation between C3-C7.

 

3. Domagoj Coric, MD, of Charlotte-based Carolina Neurosurgery and Spine Associates, and Richard Guyer, MD, of Plano-based Texas Back Institute Foundation, are serving as national co-primary investigators.

 

4. The Simplify Disc is made mostly of PEEK-on-ceramic, allowing its visibility on MRI.

 

5. The Simplify Disc already has the CE Mark.

 

More articles on devices:
Stryker achieves 95% ownership of Vexim: 5 takeaways
Zimmer Biomet, Stryker, Smith & Nephew & more: 16 device company notes
5 things to know about Stryker CEO Kevin Lobo

 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months